13 results on '"Gallo, Giuseppe Alberto"'
Search Results
2. Mobilization of Hematopoietic Stem Cells with Lenograstim in Healthy Donors: Efficacy and Safety Analysis According to Donor Age
3. Tolerability and Efficacy of Busulfan and Fludarabine As Allogeneic Pretransplant Conditioning Therapy in Acute Myeloid Leukemia: Comparison With Busulfan and Cyclophosphamide Regimen
4. Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs
5. A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant
6. A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model
7. Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?
8. Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF
9. A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy
10. I tumori e le emopatie in Calabria negli anni 1998-2001. La spesa ospedaliera per tumori in Calabria, Le sfide del futuro alla luce delle esperienze delle altre Regioni e dei Paesi Europei
11. A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study
12. Long-term results in multiple myeloma treated with high-dose melphalan and autologous peripheral stem cell transplantation and achieving complete remission.
13. A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.